Sugar-Sweetened Beverages May Raise Risk of Hepatic Cancer Subtypes
Conexiant
June 10, 2026
Higher consumption of sugar-sweetened beverages is associated with increased risks of hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
The study analyzed data from over 1.5 million patients enrolled in 11 prospective cohort studies across the United States and Europe.
Each additional daily sugar-sweetened beverage was linked to a 10% higher likelihood of hepatocellular carcinoma and a 15% higher likelihood of intrahepatic cholangiocarcinoma.
Artificially-sweetened beverage intake showed no association with hepatic cancer risk after adjusting for demographic and lifestyle factors.
Limitations of the study include reliance on self-reported beverage consumption and incomplete data on hepatitis virus infection status.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Editor
Affiliations:
Specialties:
Areas of Expertise: